84 9 Guangxi Hunan Hubei Xinjiang Qinghai Ningxia Shaanxi Hebei Shanxi Tibet Sichuan Yunan Guizhou Heilongjiang Jilin Gansu Beijing Chongqing (1)(2) 200827,440.82009 31,228.2201037,381.6
2008697.020091,296.82010 1,368.320092009 536.42010 8,075.229,149.91,725.5 21.6%78.0%4.6% 2009 70.0% 2009 78.5% 79.1%201012 3144646.0% 201012315322010 52.4%6 cgmp 85
2009 4132 2009 67.0% 200939.1%2009 11.0%201142009 201058.8% 7,60022963.8% 87955.7%2010 61.9% 920101231 1,6821,187363 4952009 10,000 86
201013.2% 200920058,660 17,205201432,651 2009201422.4% 23.4% 2009 2009 39.1% 87
201012 31532 201052.4% IIA 6 cgmp 2005Hoffmann-La Roche Ltd. 88
200454438 201012313327 6 55020.0% 20 2008200920104.126.8 76.12010123134.5 4132 2009 67.0% 201058.8% 7,600 22963.8%87955.7% 201061.9% 89
201012313320095092 100 201013.2% 90
1982 33 158 20 20101231532 91
6 2010 92
5 2009 93
20094 94
95
9 1231 2008 2009 2010.............. 6,014,432 832,288 6,846,720 6,369,666 952,961 7,322,627 7,011,995 1,063,169 8,075,164...... 19,683,695 530,522 20,214,217 23,117,630 650,884 23,768,514 28,348,117 801,810 29,149,927.............. 1,413,818 1,413,818 1,521,524 1,521,524 1,725,546 1,725,546.......... 328,816 67,979 396,795 219,343 62,017 281,360 295,910 38,975 334,885............ (1,430,789) (1,430,789) (1,665,862) (1,665,862) (1,903,954) (1,903,954)................. 27,440,761 27,440,761 31,228,163 31,228,163 37,381,568 37,381,568 2009 70.0%201020.0%20082009 20106,014.46,369.7 7,012.06,846.77,322.68,075.2 20101231950492313 24601505215 96
IIA 20101231 20101231 2010123133 276 2010123149231324 56 2010123153 2200820092010 46.5%49.7%52.4% 6 97
1231 2008 2009 2010............. 2,089.6 30.5% 2,422.0 33.1% 2,740.9 33.9%............. 2,513.4 36.7 2,621.3 35.8 2,664.4 33.0............. 626.4 9.2 819.0 11.2 1,076.9 13.3............. 673.2 9.8 560.8 7.7 683.1 8.5................ 5,902.6 86.2 6,423.1 87.8 7,165.3 88.7 (1)........... 944.1 13.8 899.5 12.2 909.9 11.3................ 6,846.7 100.0% 7,322.6 100.0% 8,075.2 100.0% (1) 20082009 20102,089.62,422.02,740.9 30.5%33.1%33.9%20101231 (1) IIA (1) (2) 98
(3) 20275 20124 (3) 20243 201312 20162 (1)(2) (1)(2) (2) (2) (2) (1) 20233 A (1) 2009100.0 (2) (3) 99
2008200920102,513.4 2,621.32,664.436.7%35.8% 33.0%2010123118 8 1152010 1231 (1) 20256 20159 (1) (1) 202711 (1) (1) 202612 (1) 20269 20258 20145 20143 (1) 20134 (1) (1) 20198 20206 (1) 2009100.0 100
200820092010 626.4819.01,076.9 9.2%11.2%13.3%20101231 2420101231 (1) (2) (1) Urinary Kallidinogenase for Injection (2) 20235 20181 202411 (1) (1) 2009100.0 (2) 200820092010 673.2560.8683.1 9.8%7.7%8.5% 101
2010123120524118 531045 23171123 20101231319 200454438 82008 35 200820092010 4.126.876.1 2010123134.5 200820092010228.8259.2 285.7 (i)(ii) (iii) 213 2010123155020.0% 2010123150 10 102
3 2010 2004 201124 20101231 103
201012313327 6 Etanercept Etanercept EtanerceptEtanercept Etanercept Etanercept 50%Etanercept LT LT LTLT50% LT2020 50% LVCR LVCR LVCRLVCR50%LVCR 104
2023 2016 BB 2024 2018 Bekhterev 20132014 2013 105
201012 312,270,000783,000 20101231 6 1231 2008 2009 2010 (1) (2) (1) (2) (1) (2).......... 41.0 76.8% 41.0 70.6% 41.0 70.0%.......... 3.6 63.8% 3.6 64.8% 3.6 65.5%........ 1.7 90.2% 1.7 100.4% 1.7 100.3%........ 1.1 59.7% 1.1 67.4% 1.1 67.5%........ 2,800.0 50.7% 2,800.0 49.5% 2,860.0 49.5% (1) (2) 200820092010 131,700 2010123122,000 106
117,000 51,000 1,581,500 20101231 13 1 107
108
1231 2008 2009 2010.............................. 3,555 3,623 3,550......................... 769 1,053 1,025..................... 701 1,126 1,221............... 68 (73) (196).............................. 3,623 3,550 3,354 20082009 2010 3012020082009 2010 200820092010 12.2%13.0%13.2% 109
200820092010 20107900 222010 10.8%2011335 2200820092010 2.1%2.4%2.6% 20113 200820092010 109.4110.5104.9 200820092010 110
20082009 2010 23.9%14.5%13.0% 18.4 60.0%10.0%30.0%1982 5030.0% 30.0% 30 TM 2008 2009201077.6105.2 89.6 Roche (China) Holding Co., Ltd. 62.4Roche (China) Holding Co., Ltd. 21.9%48.1%30.0%1994 5030.0% 30.0% CellCept 200820092010 96.9101.7120.4 111
1993 100.0200451.0%2009 640.8% 20096 200820092010 201111 20101231532 200820092010 211.5352.3491.5352.2 480.0632.0267.6 367.2512.0 2009 4132 2009 67.0% 200939.1%200911.0% 2008 2009201019,683.7 23,117.628,348.120,214.2 23,768.529,149.9 18,600 2010 61.9%4132 7,600 22963.8%87955.7% 201142009 112
1231 2008 2009 2010........... 12,366.4 62.8% 14,778.9 63.9% 17,553.6 61.9%........... 7,317.3 37.2 8,338.7 36.1 10,794.5 38.1.............. 19,683.7 100.0% 23,117.6 100.0% 28,348.1 100.0%......... 530.5 2.7 650.9 2.8 801.8 2.8....... 20,214.2 102.7% 23,768.5 102.8% 29,149.9 102.8% 201012317,60012 4132 113
20107 49.0%20108 51.0%201010 1231 2008 2009 2010............. 18,277.3 92.9% 21,481.7 92.9% 25,058.8 88.4%............. 268.7 1.4 330.0 1.4 467.0 1.6............. 136.4 0.7 210.1 0.9 884.8 3.1............. 1,001.3 5.1 1,095.8 4.7 1,937.5 6.8....... 19,683.7 100.0% 23,117.6 100.0% 28,348.1 100.0% 201012317,6002,3002,200 (i) (ii) 114
(iii)(iv) (v) 2008 20092010 200820092010 12,366.414,778.917,553.6 62.8%63.9%61.9% 115
200820092010 12311,8002,3502,300 200820092010 7,317.38,338.710,794.5 37.2%36.1%38.1% 20092 20092010 21.8201.7 116
30120 60 20082009 2010 2,6003350 92100 6688 200820092010 117
2010123118,600 2,600 20101231 2,600 2,000-3 D -2b AD (18AA) 118
1,200 1,100 1,000 700 700 570 470 470 A 450 70 119
260 120 30 80 3,000 180 120
20101231 2,600 100 80 790 (i)(ii) (iii)(iv) (v)(vi)24 (i) (ii) (iii) 6122 2009 121
H1N14254 170,000H1N1200820092010 5,00020,000 200820092010 41.938.440.8 2009 200820092010 1,413.81,521.51,725.5 122
920101231 1,6821,187363 4952009 20101231.................................... 436 323 759 (1)................................... 363 363.................................... 60 15 75.................................... 86 0 86.................................... 78 9 87.................................... 42 4 46................................... 60 144 204.................................... 40 0 40.................................... 22 0 22.................................... 1,187 495 1,682 (1) 201012311,1879 200820092010 1,413.81,521.51,725.5 20101231495 20101231 123
10,000 2322 6236 152 124
201143,569.0CHSCHS 2009 200918 201012315,000 400 1172010 51% 9 200820092010CHS3,214.44,343.4 6,111.971.494.3 131.7 2010121,487.8 96.9%100%2011 5359 20101231 66(Benazepril Hydrochloride) 125
2010491.9 2008200920101,657.71,621.9 1,414.1112.9 108.788.4 2008200920105.6%5.9% 5.1%1.4%1.4%1.2% 5% 20082009201012315,152.9 5,756.27,739.7 200820092010 566.4608.0613.5 2008200920107.7%8.4% 9.1%2.5%2.6%2.6% 5% 201012 31319 126
20101231218 20095 201010 2006 201011 2008200920105.0 3.03.9 20101231811 10 127
20095,300 2009201012 31950 2009123110,0002009 320.9% 20094.6% 2009 128
2009387,870 129
200820092010 (i)(ii) 130
200820092010 (i) (ii)(iii) 131
200820092010 ISOISO14001 200820092010 30.26.98.2 200811 132
(i) (ii) (iii)(iv) (v) 200 20112281,3861,389,383 652,322 228,128243,347 265,587 1,0761,076,079 3644,040 133
344333,505 185167,193 201212 6362,873 253287,8972011228 20.7% 2539 101 143 25310% 5725,406 20112281.8% 310 134
20 5,265 20112281647,348 16,77212 10% 2011228815445,692 373,889446 71,802369 369 7,9576 20112283,381.7 2,433.1 135
200820092010123131,85630,19031,493 20101231.................................................. 11,524 36.6%......................................... 12,315 39.1................................ 3,055 9.7....................................... 3,062 9.7 (1)................................................ 1,537 4.9................................................ 31,493 100.0% (1) 2008200920101,521.31,569.5 1,628.3 136
5 20086200580.0 2009 200920111 2011331 73.0 137